Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OASIS: Observational Study of LAIs In Schizophrenia

NCT03919994 is registered in ClinicalTrials.gov with Alkermes, Inc. as lead sponsor.

NCT NCT03919994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03919994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OASIS: Observational Study of LAIs In Schizophrenia
Lead sponsor
Alkermes, Inc.
Phase
Observational
Overall status
Completed
Start date
March 28, 2019
Completion date
January 4, 2023
Enrollment
338 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia